Oral Pathol ., 24 , 102112
Ji LQ, Hong Y, Tao YX
As obesity prevalence rises alongside ocular complications, anti-obesity medications offering both metabolic and ocular benefits may reduce eye disease burden in affected populations
HaVy Ngo-Hamilton, pharmacist and clinical consultant for BuzzRx, explains what this means: While both semaglutide and tirzepatide are administered by injection, they have different dosage schedules, rates of occurrence for potential side effects and costs, she explains
If you lose coverage (job change, plan exclusion added mid-year, or transition to Medicare), you'll need to pay out of pocket to continue treatment
I want to answer this one directly, because I get it a lot and I think theres a lot of fear around it